Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Liver Neoplasms 2Carcinoma 2

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × seocalcitol × Clear all
NCT00051532 2025-02-25

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

LEO Pharma

Phase NA Terminated
700 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

NCT00051545 2025-02-25

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

LEO Pharma

Phase 3 Terminated
608 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡